Incidence and determinants of QT interval prolongation in COVID‐19 patients treated with hydroxychloroquine and azithromycin

Author:

Maraj Ilir12,Hummel James P.1ORCID,Taoutel Roy1,Chamoun Romy1,Workman Virginia1,Li Cindy3,Tran Lydia3ORCID,DelVecchio Alexander2,Howes Christopher12,Akar Joseph G.12ORCID

Affiliation:

1. Department of Internal Medicine, Section of Cardiovascular MedicineYale School of Medicine New Haven Connecticut

2. Department of Internal MedicineGreenwich Hospital Greenwich Connecticut

3. Department of Pharmacy ServicesYale New Haven Hospital New Haven Connecticut

Publisher

Wiley

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference6 articles.

1. COVID‐19, clinical trials and QT‐prolonging prophylactic therapy in healthy subjects: first, do no harm;Gollob MH;J Am Coll Cardiol,2020

2. Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID‐19);Mercuro NJ;JAMA Cardiol,2020

3. Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID‐19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit;Bessière F;JAMA Cardiol,2020

4. Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection

5. Association of treatment with hydroxychloroquine or azithromycin with in‐hospital mortality in patients with COVID‐19 in New York State;Rosenberg ES;JAMA,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3